FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2837810867> ?p ?o ?g. }

• W2837810867 endingPage "472" @default.
• W2837810867 startingPage "461" @default.
• W2837810867 abstract "Patients with prostate cancer are at risk of impaired bone health. Prostate cancer has a propensity to metastasize to bone, after which patients are at risk of skeletal-related events (SREs). These complications are associated with increased mortality, substantial pain, and reduced quality of life. Patients are also at risk of bone loss due to androgen deprivation therapy (ADT), which can be compounded in elderly patients with reduced bone density. It is essential, therefore, that aspects of bone health and therapies able to prevent the occurrence of SREs are considered throughout the clinical course of prostate cancer. We reviewed the literature regarding the molecular mechanisms underpinning bone lesion formation, the modes of action of therapies that prevent SREs, and the efficacy and safety of these therapies in patients with hormone-sensitive or castration-resistant prostate cancer (CRPC). Therapies such as denosumab (a RANKL inhibitor) and zoledronic acid (a bisphosphonate) were indicated for prevention of SREs. Radium-223 dichloride also has proven efficacy in delaying symptomatic SREs, as well as in improving overall survival through effects on bone metastases. Before development of bone metastases, low-dose denosumab may also be used for treatment of ADT-associated bone loss. Denosumab may also have the potential to delay bone metastases development in patients with CRPC, although this is not currently an approved indication. The safety profile of therapies to prevent SREs should be considered. This review consolidates the available evidence on use of denosumab and bisphosphonates in prostate cancer, differentiated by hormone-sensitive and castration-resistant disease. There is convincing evidence to support the use of denosumab and bisphosphonates to maintain bone health in patients with prostate cancer. Clinicians should be mindful of the adverse event risk profile of these therapies." @default.
• W2837810867 created "2018-07-19" @default.
• W2837810867 creator A5000145349 @default.
• W2837810867 creator A5000710774 @default.
• W2837810867 creator A5042560676 @default.
• W2837810867 creator A5047422350 @default.
• W2837810867 date "2018-07-09" @default.
• W2837810867 modified "2023-10-16" @default.
• W2837810867 title "Harnessing the potential of therapeutic agents to safeguard bone health in prostate cancer" @default.
• W2837810867 cites W1176146861 @default.
• W2837810867 cites W1549522748 @default.
• W2837810867 cites W1606253719 @default.
• W2837810867 cites W1814843139 @default.
• W2837810867 cites W1864373894 @default.
• W2837810867 cites W1975577875 @default.
• W2837810867 cites W1980550139 @default.
• W2837810867 cites W1984673297 @default.
• W2837810867 cites W1985727076 @default.
• W2837810867 cites W1989687918 @default.
• W2837810867 cites W1992053982 @default.
• W2837810867 cites W1997161931 @default.
• W2837810867 cites W2005601855 @default.
• W2837810867 cites W2008795349 @default.
• W2837810867 cites W2011155558 @default.
• W2837810867 cites W2014574900 @default.
• W2837810867 cites W2024266959 @default.
• W2837810867 cites W2025672294 @default.
• W2837810867 cites W2028387248 @default.
• W2837810867 cites W2030521036 @default.
• W2837810867 cites W2033261019 @default.
• W2837810867 cites W2035309228 @default.
• W2837810867 cites W2037064486 @default.
• W2837810867 cites W2039962951 @default.
• W2837810867 cites W2043428481 @default.
• W2837810867 cites W2053008501 @default.
• W2837810867 cites W2054303066 @default.
• W2837810867 cites W2056592226 @default.
• W2837810867 cites W2058509951 @default.
• W2837810867 cites W2064222904 @default.
• W2837810867 cites W2064706120 @default.
• W2837810867 cites W2065574422 @default.
• W2837810867 cites W2065793218 @default.
• W2837810867 cites W2067573216 @default.
• W2837810867 cites W2072518464 @default.
• W2837810867 cites W2073309188 @default.
• W2837810867 cites W2078863172 @default.
• W2837810867 cites W2081110856 @default.
• W2837810867 cites W2084095675 @default.
• W2837810867 cites W2084959381 @default.
• W2837810867 cites W2087324367 @default.
• W2837810867 cites W2093164779 @default.
• W2837810867 cites W2100074173 @default.
• W2837810867 cites W2102969047 @default.
• W2837810867 cites W2103314990 @default.
• W2837810867 cites W2104923745 @default.
• W2837810867 cites W2107925414 @default.
• W2837810867 cites W2109333569 @default.
• W2837810867 cites W2110707581 @default.
• W2837810867 cites W2111536069 @default.
• W2837810867 cites W2112950162 @default.
• W2837810867 cites W2113701976 @default.
• W2837810867 cites W2117460748 @default.
• W2837810867 cites W2119319209 @default.
• W2837810867 cites W2124281312 @default.
• W2837810867 cites W2130687125 @default.
• W2837810867 cites W2131952914 @default.
• W2837810867 cites W2132893806 @default.
• W2837810867 cites W2136112016 @default.
• W2837810867 cites W2136646477 @default.
• W2837810867 cites W2137458001 @default.
• W2837810867 cites W2138809580 @default.
• W2837810867 cites W2139860898 @default.
• W2837810867 cites W2141454098 @default.
• W2837810867 cites W2144787894 @default.
• W2837810867 cites W2149520257 @default.
• W2837810867 cites W2150402649 @default.
• W2837810867 cites W2153871840 @default.
• W2837810867 cites W2154126390 @default.
• W2837810867 cites W2156451504 @default.
• W2837810867 cites W2161647960 @default.
• W2837810867 cites W2162514583 @default.
• W2837810867 cites W2164492215 @default.
• W2837810867 cites W2166949776 @default.
• W2837810867 cites W2210989209 @default.
• W2837810867 cites W2214621962 @default.
• W2837810867 cites W2273347348 @default.
• W2837810867 cites W2287518344 @default.
• W2837810867 cites W2297252729 @default.
• W2837810867 cites W2311786279 @default.
• W2837810867 cites W2323677330 @default.
• W2837810867 cites W2339758831 @default.
• W2837810867 cites W2466759305 @default.
• W2837810867 cites W2483834070 @default.
• W2837810867 cites W2511358444 @default.
• W2837810867 cites W2539991828 @default.
• W2837810867 cites W2545169478 @default.
• W2837810867 cites W2551943636 @default.
• W2837810867 cites W2558033492 @default.

• next